PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity

Signal Transduct Target Ther. 2022 May 27;7(1):163. doi: 10.1038/s41392-022-00970-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Morphogenetic Proteins* / metabolism
  • Hepcidins* / genetics
  • Hepcidins* / metabolism
  • Humans
  • Immunologic Deficiency Syndromes*
  • Immunosuppression Therapy
  • Tacrolimus Binding Protein 1A* / metabolism

Substances

  • Hepcidins
  • Tacrolimus Binding Protein 1A
  • Bone Morphogenetic Proteins